AV-105

• Description:

  AV-105 is a Florbetapir (18F) -radiolabeled slyrylpyridine tosylate precursor extracted from patent WO2010078370A1, example 1.5. AV-105 can synthesize 18F-radiolabeled compounds, which are used for positron emission tomography (PET) imaging of neurodegenerative diseases of the brain[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H319

• Target:

  Drug Intermediate

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Neuroscience-Neurodegeneration

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/av-105.html

• Concentration:

  10mM

• Purity:

  99.70

• Solubility:

  DMSO : 62.5 mg/mL (ultrasonic)

• Smiles:

  O=C (OC (C) (C) C) N (C) C1=CC=C (/C=C/C2=CC=C (OCCOCCOCCOS (=O) (C3=CC=C (C) C=C3) =O) N=C2) C=C1

• Molecular Formula:

  C32H40N2O8S

• Molecular Weight:

  612.73

• Precautions:

  H319

• References & Citations:

  [1]Tyler Benedum, et al. Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof. WO2010078370A1.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  1205550-99-7